Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B.ST
Clinical Laserthermia Systems AB (publ)SE flagStockholm Stock Exchange
2.84
SEK
-0.06
(-2.07%)
-4.30EPS
-0.66P/E
56.82MMarket Cap
May 16Next Earn

Clinical Laserthermia Systems AB (publ) (CLS-B.ST) Stock Splits

Learn about Clinical Laserthermia Systems AB (publ)'s most recent 519-for-500 basis stock split on June 07, 2024. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Clinical Laserthermia Systems AB (publ)'s most recent stock split

Split Date: 2024-06-07
Split Ratio: 519:500
Price Before Split: $6.55
Price After Split: $6.31

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.04 times more shares (a 519:500 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Clinical Laserthermia Systems AB (publ)'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-06-07519:500No$6.55$6.31
2024-04-251:200Yes$0.09N/A
2023-06-143077:1000No$23698.93$7701.96
2022-08-17309:250No$200858.60$162506.95
2021-04-08517:500No$644942.42$623735.42
2020-01-14519:500No$1121964.70$1080890.85
2017-01-261037:1000No$1591986.82$1535184.98
2016-01-191019:1000No$1300219.72$1275976.17
2014-10-29127:125No$1640721.01$1614882.88
2013-10-02107:100No$3405813.73$3183003.48
2012-05-02127:125No$1382989.26$1361209.90
2012-01-181017:1000No$941592.91$925853.40
2010-01-211017:1000No$516490.83$507857.26

About Clinical Laserthermia Systems AB (publ)

Company overview and industry information

Clinical Laserthermia Systems AB (publ) (CLS-B.ST) operates in the Medical - Devices industry. The recent 519-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Medical - Devices
Go to Clinical Laserthermia Systems AB (publ) Summary

Last updated: 3/20/2025

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.